Telehealth during COVID-19 restrictions in patients with cardiovascular disease: impact on medication prescriptions and patient satisfaction.

Telehealth during COVID-19 restrictions in patients with cardiovascular disease: impact on medication prescriptions and patient satisfaction.

Publication date: Mar 20, 2024

Telehealth plays an integral part in healthcare delivery. The impact of telehealth and the COVID-19 pandemic on medication prescribing and patient satisfaction with telehealth in cardiology clinics remains unknown. A retrospective study of cardiology clinic patients at an Australian tertiary hospital was conducted; 630 patients seen before the COVID-19 pandemic (0. 6% telehealth) and 678 during the pandemic (91. 2% telehealth) were included. Medication changes, new prescriptions and time to obtaining prescriptions after clinic were compared. To evaluate patients’ experiences, cardiology clinic patients reviewed during the pandemic were prospectively invited to participate in an electronic survey sent to their mobile phones. The overall rates of medication changes made in the clinic between the prepandemic and the pandemic periods did not differ significantly (26. 9% vs 25. 8%). Compared with prepandemic, new cardiac medication prescriptions during clinic were significantly less (9. 3% vs 2. 5%; P

Concepts Keywords
Australian cardiovascular
Cardiology COVID-19
Pandemic medication prescription
Phones telehealth

Semantics

Type Source Name
disease MESH COVID-19
disease MESH cardiovascular disease
disease VO time

Original Article

(Visited 1 times, 1 visits today)